Aarti Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0LRU01027
  • NSEID: AARTIPHARM
  • BSEID: 543748
INR
659.90
10.85 (1.67%)
BSENSE

Jun 18

BSE+NSE Vol: 1.42 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Net Sales
1,819.44
2,115.07
1,852.61
1,945.23
1,199.94
0.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,819.44
2,115.07
1,852.61
1,945.23
1,199.94
0.00
Raw Material Cost
830.06
835.80
858.45
1,014.30
611.24
0.00
Purchase of Finished goods
55.95
176.63
182.22
280.82
162.92
0.00
(Increase) / Decrease In Stocks
-51.18
64.22
-19.95
-125.36
-49.05
0.00
Employee Cost
173.09
161.96
138.41
129.69
85.20
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
442.31
412.10
307.43
303.74
182.68
0.00
Total Expenditure (Excl Depreciation)
1,450.23
1,650.71
1,466.56
1,603.19
992.99
0.00
Operating Profit (PBDIT) excl Other Income
369.21
464.36
386.05
342.04
206.95
0.00
Other Income
9.75
10.12
4.90
2.32
2.51
0.00
Operating Profit (PBDIT)
378.96
474.48
390.95
344.36
209.46
0.00
Interest
46.90
26.90
17.21
21.05
11.96
0.00
Exceptional Items
-2.79
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
329.27
447.58
373.74
323.31
197.50
0.00
Depreciation
104.34
86.90
73.24
62.54
42.12
0.00
Profit Before Tax
224.92
360.69
300.49
260.77
155.38
0.00
Tax
58.21
88.28
83.59
67.28
33.13
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
166.71
272.40
216.90
193.49
122.25
0.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
166.71
272.40
216.90
193.49
122.25
0.00
Share in Profit of Associates
8.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
174.71
272.40
216.90
193.49
122.25
0.00
Equity Capital
45.33
45.32
45.31
45.31
45.56
0.25
Face Value
5.0
5.0
5.0
5.0
10.0
10.0
Reserves
2,079.28
1,944.59
1,711.72
1,513.17
0.00
0.00
Earnings per share (EPS)
19.27
30.05
23.94
21.35
26.83
0.0
Diluted Earnings per share
19.25
30.04
23.93
21.35
13.49
-0.18
Operating Profit Margin (Excl OI)
20.29%
21.95%
20.84%
17.58%
17.25%
0.0%
Gross Profit Margin
18.1%
21.16%
20.17%
16.62%
16.46%
0.0%
PAT Margin
9.6%
12.88%
11.71%
9.95%
10.19%
0.0%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is -13.98% vs 14.17% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2026 is -35.86% vs 25.59% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is -20.49% vs 20.28% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 74.35% vs 56.30% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2026 has fallen from Mar 2025

Compare Annual Results Of Aarti Pharma With
Markets Mojo
Figures in Cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,819.44
2,170.93
-351.49
-16.19%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,819.44
2,170.93
-351.49
-16.19%
Raw Material Cost
830.06
576.37
253.69
44.02%
Purchase of Finished goods
55.95
127.60
-71.65
-56.15%
(Increase) / Decrease In Stocks
-51.18
6.99
-58.17
-832.19%
Employee Cost
173.09
482.55
-309.46
-64.13%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
442.31
631.33
-189.02
-29.94%
Total Expenditure (Excl Depreciation)
1,450.23
1,824.84
-374.61
-20.53%
Operating Profit (PBDIT) excl Other Income
369.21
346.09
23.12
6.68%
Other Income
9.75
113.52
-103.77
-91.41%
Operating Profit (PBDIT)
378.96
459.61
-80.65
-17.55%
Interest
46.90
4.99
41.91
839.88%
Exceptional Items
-2.79
-20.79
18.00
86.58%
Gross Profit (PBDT)
329.27
433.83
-104.56
-24.10%
Depreciation
104.34
59.24
45.10
76.13%
Profit Before Tax
224.92
374.60
-149.68
-39.96%
Tax
58.21
93.18
-34.97
-37.53%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
166.71
281.42
-114.71
-40.76%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
166.71
281.42
-114.71
-40.76%
Share in Profit of Associates
8.00
0.00
8.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
174.71
281.42
-106.71
-37.92%
Equity Capital
45.33
16.28
29.05
178.44%
Face Value
5.00
1.00
0.00
Reserves
2,079.28
2,468.83
-389.55
-15.78%
Earnings per share (EPS)
19.27
17.29
1.98
11.45%
Diluted Earnings per share
19.25
17.29
1.96
11.34%
Operating Profit Margin (Excl OI)
20.29%
15.94%
0.00
4.35%
Gross Profit Margin
18.10%
19.98%
0.00
-1.88%
PAT Margin
9.60%
12.96%
0.00
-3.36%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 1,819.44 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -13.98% vs 14.17% in Mar 2025

Annual - Consolidate Net Profit
Consolidate Net Profit 174.71 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -35.86% vs 25.59% in Mar 2025

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 369.21 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -20.49% vs 20.28% in Mar 2025

Annual - Interest
Interest 46.90 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 74.35% vs 56.30% in Mar 2025

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 20.29%
in Mar 2026

Figures in %
stock-summary

YoY Growth in year ended Mar 2026 has fallen from Mar 2025

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther

Name: MOJO Markets Private Limited (Research Entity) (SEBI Registration No. INH000021942) (CIN:U74900MH2015PTC264951)

Registered & Correspondence Address: Benefice Business House, Office No. 3B, 3rd Floor, C.S. 242, Mathuradas Mills Estate, N.M. Joshi Marg, Tulsi Pipe Road, Lower Parel West, Mumbai- 400013

For queries or grievances, please contact us on support.ra@mojomarkets.in, Phone : 022-35121239

"Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors."